Penumbra

Penumbra's 15-min chart indicates MACD Death Cross, BB expanding downward.

Penumbra's 15min chart shows Bollinger Bands expanding downward with KDJ death cross.

Boston Scientific

Boston Scientific (BSX) Surges Amid Penumbra Acquisition, Analysts Bullish on Future Growth

Boston Scientific's Valuation After Penumbra Deal and Recent Share Moves: A Closer Look

Catalyst<ul> <li>Small, Medium, and Large order-size fund flows show positive net inflow trends, suggesting accumulating institutional confidence in PEN.</li></ul>Risk<ul> <li>Technical analysis indicates bearish signals are dominant with 4 negative and 1 positive indicator, suggesting a higher likelihood of downward movement.</li> <li>Analyst ratings for PEN show significant divergence, with 11 out of 12 analysts assigning Neutral ratings, indicating a lack of strong consensus or confidence in the stock's direction.</li></ul>

Key Factors

Penumbra's stock surged 11.8% the day after its Q4 earnings report on January 15, 2026, with shares rising 29.3% to trade near $342 by the following weeks. On February 5, 2026, Penumbra's stock closed up 0.61% after a $640 million volume surge, ranking 251st in market activity.

PEN News